Cadila Healthcare Ltd (CADILAHC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Cadila Healthcare Ltd (Zydus Cadila) is an integrated, global healthcare provider. It discovers, develops, manufactures and markets various healthcare products. The companys product portfolio includes active pharmaceutical ingredients (APIs), formulations, wellness and animal health products. Zydus Cadilas products find application in the treatment of diseases in the therapeutic areas of gastrointestinal, cardiovascular, respiratory, pain management, cancer, inflammation, neurology, and womens health, among others. It conducts research to develop biologics, vaccines and new chemical entities. The company has manufacturing facilities in Brazil and India. It has presence in the US, Europe, South Africa, Japan, Brazil, and other emerging markets. Zydus Cadila is headquartered in Ahmedabad, Gujarat, India.

Cadila Healthcare Ltd (CADILAHC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 5
List of Figures 5
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Cadila Healthcare Ltd, Medical Devices Deals, 2012 to YTD 2018 11
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deal Details 14
Asset Purchase 14
Zydus Cadila Healthcare May Acquire 8 brands from Astrazeneca India 14
Zydus Healthcare Acquires Six Brands from Merck 15
Zydus Cadila Healthcare Acquires Rights to Melgain from Issar Pharma 16
Zydus Cadila Healthcare Announces Acquisition of Two Abbreviated New Drug Applications form Teva Pharma 17
Zydus Cadila Healthcare to Acquire Actibile from Albert David for USD8.2 Million 18
Sentynl Therapeutics Acquires Abstral from Galena Biopharma 19
Private Equity 20
Cipla, Zydus Cadilla, Dr. Reddys Labs and Baring Asia May Acquire Bharat Serums and Vaccines 20
Partnerships 22
Zydus Cadila Healthcare to Enter into Agreement with Medicure International 22
Cadila Healthcare Enters into Agreement with Pharm Aid 23
Zydus Cadila Healthcare Enters into Agreement with Medicines for Malaria Venture 24
Zydus Cadila Healthcare Enters into Agreement with Takeda Pharma 25
Zydus Cadila and Eczacibasi Enter into Agreement 26
Zydus Cadila Healthcare Enters into Research Agreement with National Institute of Allergy and Infectious Diseases 27
Zydus Cadila Enters Into Co-Development Agreement With Pieris For Anticalin Therapeutics 28
IDRI And Zydus Cadila Healthcare Enter Into Agreement To Develop Vaccine Candidate For Visceral Leishmaniasis 30
Zydus Cadila On The Lookout For Partners To Market New Chemical Entity, Lipaglyn 31
Zydus Cadila To Terminate Co-Development Agreement With Eli Lilly 32
Licensing Agreements 33
Supernus Pharma Enters into Licensing Agreement with Zydus Pharma 33
Zydus Cadila Healthcare Enters into Licensing Agreement with Neovii Biotech 34
Zydus Cadila Healthcare Enters into Licensing Agreement with Medicines Patent Pool 35
Gilead Sciences Enters into Licensing Agreement with Cadila Healthcare 36
Equity Offering 37
Cadila Healthcare to Raise Funds in Public Offering of Securities 37
Asset Transactions 38
Zydus Healthcare to Acquire India Human Formulations Undertaking from Cadila Healthcare for USD10.2 Million 38
Acquisition 39
Cadila Healthcare Acquires 51% Stake in Windlas Healthcare for USD22.5 Million 39
Zydus Cadila Healthcare Acquires Sentynl Therapeutics for USD171 Million 40
Zydus Cadila Healthcare To Sell Nippon Universal Pharma 41
Cadila Healthcare Ltd - Key Competitors 42
Cadila Healthcare Ltd - Key Employees 43
Cadila Healthcare Ltd - Locations And Subsidiaries 44
Head Office 44
Other Locations & Subsidiaries 44
Joint Venture 46
Recent Developments 48
Financial Announcements 48
May 25, 2018: Zydus Cadilas Net Profit up by 53% in Q4 48
Feb 08, 2018: Zydus Cadilas EBIDTA up by 108% in Q3 49
Feb 07, 2018: Zydus Wellness Consolidated Net profit up by 43.8% in Q3 50
Nov 14, 2017: Zydus Cadilas EBIDTA up by 68% in Q2 51
May 27, 2017: Zydus Cadila registers Net Profit of Rs. 1488 crores in FY 17 52
Jan 31, 2017: Cadila Healthcare Announces Q3 results 53
Legal and Regulatory 54
Oct 09, 2018: Astrazeneca sues block Zydus Cadila bid generic nexium 54
Oct 04, 2018: Cadila Healthcares manufacturing facility Zydus Biologics receives an Establishment Inspection Report from USFDA 55
Aug 29, 2018: Zydus Cadila: Update on USFDA inspection of injectables manufacturing facility of Liva Pharmaceuticals 56
Aug 29, 2018: Cadila Healthcare intimates of USFDA inspection of Liva Pharmaceuticals 57
Aug 24, 2018: Cadila Healthcares Biologics manufacturing facility successfully completes USFDA inspection 58
Jun 06, 2018: Cadila Healthcare: USFDA inspection of wholly-owned subsidiary, Alidac Pharmaceuticals Ltd., located at SEZ, Ahmedabad 59
Mar 28, 2018: Cadila Healthcare announces successfully completion of USFDA inspection at Topical facility 60
Feb 09, 2018: Cadila Healthcares Moraiya facility successfully completes USFDA inspection 61
Jan 19, 2018: Cadila Healthcare Announces Completion Of USFDA Inspection At Dabhasa, India Facility 62
Sep 07, 2017: Cadila Healthcares Moraiya facility successfully completes USFDA inspection 63
Aug 29, 2017: Zydus receives EIR Report for Manufacturing Facility at the Pharma SEZ at Ahmedabad 64
Jun 21, 2017: Zydus receives EIR Report for Moraiya Manufacturing Facility 65
Apr 07, 2017: Cadila Healthcare Provides Update on US FDA Inspection at Changodar Manufacturing Facility 66
Feb 16, 2017: Cadila Healthcare Provides Update On USFDA Inspection Of Moraiya Facility 67
Product News 68
Nov 29, 2017: New diagnostic kits developed to detect rare and neglected infectious diseases 68
Clinical Trials 69
Nov 20, 2017: Zydus Oral Anemia Developmental Candidate, ZYAN1 Named as Desidustat by WHO 69
Jul 05, 2017: Zydus starts phase II trial of ZYAN1 for treating anemia in patients with CKD 70
Appendix 71
Methodology 71
About GlobalData 71
Contact Us 71
Disclaimer 71

List Of Tables


Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Cadila Healthcare Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Cadila Healthcare Ltd, Medical Devices Deals, 2012 to YTD 2018 11
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Zydus Cadila Healthcare May Acquire 8 brands from Astrazeneca India 14
Zydus Healthcare Acquires Six Brands from Merck 15
Zydus Cadila Healthcare Acquires Rights to Melgain from Issar Pharma 16
Zydus Cadila Healthcare Announces Acquisition of Two Abbreviated New Drug Applications form Teva Pharma 17
Zydus Cadila Healthcare to Acquire Actibile from Albert David for USD8.2 Million 18
Sentynl Therapeutics Acquires Abstral from Galena Biopharma 19
Cipla, Zydus Cadilla, Dr. Reddys Labs and Baring Asia May Acquire Bharat Serums and Vaccines 20
Zydus Cadila Healthcare to Enter into Agreement with Medicure International 22
Cadila Healthcare Enters into Agreement with Pharm Aid 23
Zydus Cadila Healthcare Enters into Agreement with Medicines for Malaria Venture 24
Zydus Cadila Healthcare Enters into Agreement with Takeda Pharma 25
Zydus Cadila and Eczacibasi Enter into Agreement 26
Zydus Cadila Healthcare Enters into Research Agreement with National Institute of Allergy and Infectious Diseases 27
Zydus Cadila Enters Into Co-Development Agreement With Pieris For Anticalin Therapeutics 28
IDRI And Zydus Cadila Healthcare Enter Into Agreement To Develop Vaccine Candidate For Visceral Leishmaniasis 30
Zydus Cadila On The Lookout For Partners To Market New Chemical Entity, Lipaglyn 31
Zydus Cadila To Terminate Co-Development Agreement With Eli Lilly 32
Supernus Pharma Enters into Licensing Agreement with Zydus Pharma 33
Zydus Cadila Healthcare Enters into Licensing Agreement with Neovii Biotech 34
Zydus Cadila Healthcare Enters into Licensing Agreement with Medicines Patent Pool 35
Gilead Sciences Enters into Licensing Agreement with Cadila Healthcare 36
Cadila Healthcare to Raise Funds in Public Offering of Securities 37
Zydus Healthcare to Acquire India Human Formulations Undertaking from Cadila Healthcare for USD10.2 Million 38
Cadila Healthcare Acquires 51% Stake in Windlas Healthcare for USD22.5 Million 39
Zydus Cadila Healthcare Acquires Sentynl Therapeutics for USD171 Million 40
Zydus Cadila Healthcare To Sell Nippon Universal Pharma 41
Cadila Healthcare Ltd, Key Competitors 42
Cadila Healthcare Ltd, Key Employees 43
Cadila Healthcare Ltd, Other Locations 44
Cadila Healthcare Ltd, Subsidiaries 44
Cadila Healthcare Ltd, Joint Venture 46

List Of Figures


Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Cadila Healthcare Ltd, Medical Devices Deals, 2012 to YTD 2018 11

Cadila Healthcare Ltd (CADILAHC) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Cadila Healthcare Ltd (Zydus Cadila) is an integrated, global healthcare provider. It discovers, develops, manufactures and markets various healthcare products. The companys product portfolio includes active pharmaceutical ingredients (APIs), formulations,

USD 250 View Report

Cadila Pharmaceuticals Ltd - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Cadila Pharmaceuticals Ltd (Cadila Pharmaceuticals) is a pharmaceutical company that develops, manufactures and distributes pharmaceutical products. Its products include active pharmaceutical ingredients (API) and pharmaceutical formulations. The companys products are

USD 250 View Report

Regis Healthcare Ltd - Strategy, SWOT and Corporate Finance Report

Regis Healthcare Ltd - Strategy, SWOT and Corporate Finance ReportRegis Healthcare Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report

USD 175 View Report

Novita Healthcare Ltd (NHL) - Medical Equipment - Deals and Alliances Profile

Novita Healthcare Ltd (Novita Healthcare), formerly Avexa Ltd is a medical technology company that focuses on the measurement and treatment of attention difficulties in early childhood. The company operates through

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available